Keith Westby, SVP, Chief Operating Officer at IVERIC bio, Inc. (ISEE), sold 80,000 shares at $26.98 ($2.1M) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($2.1M) by SVP, Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.35 | 17,470 | $460K | 21.5% |
| 2 | $26.35 | 17,470 | $460K | 21.5% |
| 3 | $26.98 | 22,530 | $608K | 28.5% |
| 4 | $26.98 | 22,530 | $608K | 28.5% |
| Total | $26.70 avg | 80,000 | $2.1M | 100% |
| Filing → |
| ISEE | SELL | 2023-05-03 | $2.2M | — | Filing → |
| ISEE | SELL | 2023-04-25 | $1.2M | — | Filing → |
| ISEE | SELL | 2023-03-06 | $479K | — | Filing → |